Market Highlights:
Barlow’s Syndrome is a condition in which there is an abnormality of the mitral valve of the heart. It is a condition in which the leaflets of the mitral valve swell into the left atrium of the heart as the valve closes during ventricular contraction. This abnormality prevents the valve from closing correctly, which causes it to leak.
The global Barlow’s Syndrome market is expected to grow at a CAGR of 9% during the forecast period.
Access Report Details @ https://www.marketresearchfuture.com/reports/barlow-syndrome-market-5596
Segmentation
The global Barlow’s Syndrome market is segmented on the basis of type, treatment, diagnosis, and end-users.
On the basis of the type, the market is segmented as mitral valve stenosis, mitral valve prolapse, and mitral valve regurgitation.
On the basis of the treatment, the market is segmented into medications and surgery. Medications are further sub-segmented to beta-blockers and calcium blockers. The beta blockers further sub-segmented to atenolol and metoprolol. The calcium blockers are further sub-segmented into Verapamil and Diltiazem.
On the basis of the diagnosis, the market is segmented into X-ray, electrocardiogram, and echocardiogram.
On the basis of the end user, the market is segmented into hospitals & surgical centers, research institutes, and specialty clinics.
Key Players
Some of the key players in the barlows syndrome market are Abbott, Medtronic, Edward Lifesciences Corporation, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Lepu Medical Technology Co., Ltd Neovasc, Inc., Sorin Group, TTK HealthCare, JenaValve Technology, Inc. among others.
No comments:
Post a Comment